A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of ...

According to expert presenters at the American Society of Preventive Cardiology’s 2025 Congress on Cardiovascular Disease Prevention, recent studies have shown significant benefit to GLP-1 inhibitors ...

When given nutritionally matched diets, participants lost twice as much weight eating minimally processed foods compared to ...

Tana Mongeau has warned people against using Mounjaro for weight loss, after experiencing crippling side effects on the ...

Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...

The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some success ...

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, ...

Topline results from the SURPASS-CVOT trial reveal that once-weekly tirzepatide (Mounjaro) has a cardiovascular risk profile ...